• Accueil >
  • Publications >
  • Response to salvage chemotherapy after progression on immune checkpoint inhibitors in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck

Response to salvage chemotherapy after progression on immune checkpoint inhibitors in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck

1 nov. 2019European Journal of Cancer

DOI : 10.1016/j.ejca.2019.08.026

Auteurs

Khalil Saleh, Amaury Daste, Nicolas Martin, Elvire Pons-Tostivint, Anne Auperin, Ruth Gabriela Herrera-Gomez, Neus Baste-Rotllan, Francois Bidault, Joel Guigay, Christophe Le Tourneau, Esma Saada-Bouzid, Caroline Even